Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 4:12:1106596.
doi: 10.3389/fcimb.2022.1106596. eCollection 2022.

Streptococcus pneumoniae meningitis and the CNS barriers

Affiliations
Review

Streptococcus pneumoniae meningitis and the CNS barriers

Eliza Gil et al. Front Cell Infect Microbiol. .

Abstract

Streptococcus pneumoniae (SPN) is a globally significant cause of meningitis, the pathophysiology of which involves damage to the brain by both bacterial virulence factors and the host inflammatory response. In most cases of SPN meningitis bacteria translocate from the blood into the central nervous system (CNS). The principal site of SPN translocation into the CNS is not known, with possible portals of entry proposed to be the cerebral or meningeal blood vessels or the choroid plexus. All require SPN to bind to and translocate across the vascular endothelial barrier, and subsequently the basement membrane and perivascular structures, including an additional epithelial barrier in the case of the blood-CSF barrier. The presence of SPN in the CNS is highly inflammatory resulting in marked neutrophilic infiltration. The secretion of toxic inflammatory mediators by activated neutrophils within the CNS damages pathogen and host alike, including the non-replicative neurons which drives morbidity and mortality. As with the translocation of SPN, the recruitment of neutrophils into the CNS in SPN meningitis necessitates the translocation of neutrophils from the circulation across the vascular barrier, a process that is tightly regulated under basal conditions - a feature of the 'immune specialization' of the CNS. The brain barriers are therefore central to SPN meningitis, both through a failure to exclude bacteria and maintain CNS sterility, and subsequently through the active recruitment and/or failure to exclude circulating leukocytes. The interactions of SPN with these barriers, barrier inflammatory responses, along with their therapeutic implications, are explored in this review.

Keywords: Streptococcus pneumoniae; blood-CSF barrier; blood-brain barrier; meningitis; neutrophil recruitment; pericytes; pneumococcal meningitis; streptococcal infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Østergaard C., Brandt C., Konradsen H. B., Samuelsson S. (2004). Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models. J. Infect. Dis. 190, 1212–1220. doi: 10.1086/423852 - DOI - PubMed
    1. Abbott N. J., Rönnbäck L., Hansson E. (2006). Astrocyte–endothelial interactions at the blood–brain barrier. Nat. Rev. Neurosci. 7, 41–53. doi: 10.1038/nrn1824 - DOI - PubMed
    1. Abtin A., Jain R., Mitchell A. J., Roediger B., Brzoska A. J., Tikoo S., et al. . (2014). Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat. Immunol. 15, 45–53. doi: 10.1038/ni.2769 - DOI - PMC - PubMed
    1. Alcendor D. J., Charest A. M., Zhu W. Q., Vigil H. E., Knobel S. M. (2012). Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J. Neuroinflamm. 9, 95. doi: 10.1186/1742-2094-9-95 - DOI - PMC - PubMed
    1. Ampie L., McGavern D. B. (2022). Immunological defense of CNS barriers against infections. Immunity 55, 781–799. doi: 10.1016/j.immuni.2022.04.012 - DOI - PMC - PubMed

Publication types